For the first time, the use of the Corona drug has been approved: the
UK will begin experimental administration of the Merck Corona drug to Corona patients across the country.
This was announced today (Sunday) by Susan Hopkins, head of the British Medical Safety Organization.
Hopkins did not elaborate on the number of patients receiving the new antiviral therapy, which the company claims reduces the chances of hospitalization as a result of coronary heart disease by more than fifty percent, but claimed that the British health system has hundreds of thousands of doses of the new drug.
Last week, London approved the drug from the British company as a treatment for coronary heart disease, making it the first country to approve this type of antiviral treatment.
MERCK Corona Drug Capsules, Photo: Merck & Co, Inc.
/ AFP
As a reminder, Pfizer revealed over the weekend that it has developed a pill against the corona virus and that it is 89% effective in preventing death and serious illness in adults, while reducing the risk of hospitalization.
Also, in the study population no deaths were reported as a result of receiving the pill.
Pfizer CEO Albert Burla said the company plans to submit data from the study's interim analysis to the FDA in order to get approval for the pill's use.
